Shiyi Li

2PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 04, 2026
A real-world study on treatment after TKI progression in HER2-positive MBC.

|Feb 17, 2026
Phase II trial of anlotinib-chemotherapy combination in pretreated HER2-negative metastatic breast cancer: therapeutic efficacy and proteomic biomarker profiling.

Ting Xu, Quan Gu, Shiyi Li

Pageof 1

Frequent Collaborators

2 joint publications

Ting Xu

2 joint publications

Yuan Yuan

1 joint publications

Quan Gu

1 joint publications

Lili Zhang